Medinotec (MDNC) Cost of Revenue (2022 - 2026)

Medinotec (MDNC) has reported Cost of Revenue for 5 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 10.04% year-over-year to $1.3 million; the trailing twelve-month figure through May 2026 stood at $4.7 million (down 3.28% YoY), and the FY2026 full-year result was $4.6 million, up 7.13% from the prior year.
• Cost of Revenue rose to $1.3 million in Q2 2026 per MDNC's latest filing, from $967581.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $1.5 million in Q4 2024 and bottomed at $49436.0 in Q3 2022.
• Historically, Cost of Revenue has averaged $770298.2 across 5 years, with a median of $969094.5 in 2024.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue sank 79.9% in 2023, then jumped 1491.47% in 2024.
• Over 5 years, Cost of Revenue stood at $164685.0 in 2022, then surged by 591.4% to $1.1 million in 2023, then soared by 33.87% to $1.5 million in 2024, then slipped by 21.87% to $1.2 million in 2025, then grew by 12.8% to $1.3 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $1.3 million, $967581.0, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.